DiabeDoc

14/11/2025

Attending MAPCON 2025 at Mahableshwar.

14/11/2025

The theme for the International Diabetes Federation (IDF) World Diabetes Day 2025 is "Diabetes and Well-being", with a specific focus on "Diabetes and the Workplace". This is part of a multi-year campaign running from 2024–2026 under the umbrella of "Diabetes and Well-being".

12/11/2025

Glimpse of RSSDI Kochi 2025.

02/11/2025

Weight loss drugs like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are considered "game changers" due to their high effectiveness, mimicking hormones that regulate appetite to help people lose significant weight. These medications are most effective when used with lifestyle changes, medical supervision, and a realistic understanding of their use, and are not a quick fix.

Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However, access

02/11/2025

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk & stroke in type 2 diabetes patients. The drug can be prescribed to reduce major adverse cardiovascular issues even in patients who have not yet experienced these events.

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, for managing cardiovascular risks in adults. This medication, previously for typ

31/10/2025

Every day some self claimed Nutritionist ,babaji appear on social media and misguide the innocent public by creating controversial podcast for getting views and followers .
Some of these fake gurus are conducting even webinar to trap the innocent public with very high fee structure.
Jago - Jago - Jago
Be careful from these kind of fraudsters, Cyber thugs on social media.

25/08/2025

In a study, patients with neuropathic pruritus showed significantly higher rates of anxiety, depression, sleep disorders, type 2 diabetes, obesity, and falls than healthy individuals. Gabapentin and topical corticosteroids were the most prescribed treatment agents with high success rates. http://ms.spr.ly/6187spkhf

25/08/2025

Using metformin, a traditionally prescribed diabetes drug, is linked to an 8%-12% lower risk for dementia in patients with overweight or obesity. http://ms.spr.ly/6183srtVZ

16/08/2025

A Lancet Global Health study reveals that nearly 40% of Indian diabetics are unaware of their condition, with a 20% prevalence among adults aged 45 and above. Urban areas show double the diabetes rates compared to rural regions. The study emphasizes the urgent need for improved prevention, detection...

25/07/2025

Review: 7,000 steps a day enough for health benefits

A review in The Lancet Public Health suggests 7,000 steps daily may suffice for health benefits, challenging the 10,000-step target. The analysis of data for more than 160,000 adults found 7,000 steps reduced risks for death, heart disease and other conditions, with benefits plateauing beyond that.

THURSDAY, July 23, 2025 (HealthDay News) — Walkers don’t need to march 10,000 steps a day to gain substantial health benefits, a comprehensive new evidence revi

25/07/2025

*Non invasive glucometer* on social media marketing:
FACTS

No, there are currently no non-invasive glucometers fully approved by the FDA for use in India or anywhere else. While some non-invasive technologies are in development and undergoing trials, none have achieved the necessary accuracy and safety standards for widespread approval. The FDA has cleared some continuous glucose monitoring (CGM) systems, like the FreeStyle Libre and Dexcom G6, but these still require a sensor to be inserted under the skin, making them minimally invasive rather than fully non-invasive.

25/07/2025

Newer drugs for managing obesity.
Dr. Shashank Joshi, Endocrinologist, Mumbai

Are weight loss drugs the magic pill that people are talking about? Listen to what India’s leading Endocrinologist Padma Shri Dr. Shashank Joshi has to say ...